These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 24053150
1. Clinical trial risk in castration-resistant prostate cancer: immunotherapies show promise. Tenuta A, Klotz L, Parker JL. BJU Int; 2014 May; 113(5b):E82-9. PubMed ID: 24053150 [Abstract] [Full Text] [Related]
2. [Current status and future direction of the treatment of CRPC (castration resistant prostate cancer)]. Akaza H. Nihon Rinsho; 2014 Dec; 72(12):2108-15. PubMed ID: 25518342 [Abstract] [Full Text] [Related]
13. Using surrogate biomarkers to predict clinical benefit in men with castration-resistant prostate cancer: an update and review of the literature. Armstrong AJ, Febbo PG. Oncologist; 2009 Aug; 14(8):816-27. PubMed ID: 19684076 [Abstract] [Full Text] [Related]
14. The utility of prostate-specific antigen in the management of advanced prostate cancer. Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP. BJU Int; 2013 Sep; 112(5):548-60. PubMed ID: 23826876 [Abstract] [Full Text] [Related]